Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

NovaBridge Biosciences (NBP) Shares Outstanding (Weighted Average) (2017 - 2025)

NovaBridge Biosciences (NBP) has 9 years of Shares Outstanding (Weighted Average) data on record, last reported at $220.3 million in Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 183549010.0% to $220.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $220.3 million, a 183549010.0% increase, with the full-year FY2025 number at $220.3 million, up 183549010.0% from a year prior.
  • Shares Outstanding (Weighted Average) reached $220.3 million in Q4 2025 per NBP's latest filing, up from $80.0 in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for NBP hit a ceiling of $220.3 million in Q4 2025 and a floor of $20.0 in Q1 2025.
  • A 5-year average of $52.7 million and a median of $210.0 in 2024 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): tumbled 100.0% in 2024, then soared 183549010.0% in 2025.
  • Tracing NBP's Shares Outstanding (Weighted Average) over 5 years: stood at $27.3 million in 2021, then fell by 2.35% to $26.7 million in 2022, then dropped by 0.37% to $26.6 million in 2023, then tumbled by 100.0% to $120.0 in 2024, then skyrocketed by 183549010.0% to $220.3 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for NBP at $220.3 million in Q4 2025, $80.0 in Q3 2025, and $50.0 in Q2 2025.